Works matching IS 00099236 AND DT 2006 AND VI 79 AND IP 4
Results: 14
Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 291, doi. 10.1016/j.clpt.2005.11.011
- By:
- Publication type:
- Article
Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: Implication for the adverse effects of cyclooxygenase-2 inhibitors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 303, doi. 10.1016/j.clpt.2005.12.306
- By:
- Publication type:
- Article
Environmental and genetic factors associated with morphine response in the postoperative period.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 316, doi. 10.1016/j.clpt.2006.01.007
- By:
- Publication type:
- Article
MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 325, doi. 10.1016/j.clpt.2005.11.013
- By:
- Publication type:
- Article
Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 339, doi. 10.1016/j.clpt.2005.11.015
- By:
- Publication type:
- Article
Comparison of midazolam and simvastatin as cytochrome P450 3A probes<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 350, doi. 10.1016/j.clpt.2005.11.016
- By:
- Publication type:
- Article
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 362, doi. 10.1016/j.clpt.2005.12.305
- By:
- Publication type:
- Article
Analgesic effect of acetaminophen in humans: First evidence of a central serotonergic mechanism.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 371, doi. 10.1016/j.clpt.2005.12.307
- By:
- Publication type:
- Article
A therapeutic substitution policy for proton pump inhibitors: Clinical and economic consequences<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 379, doi. 10.1016/j.clpt.2005.12.304
- By:
- Publication type:
- Article
Severe arrhythmia as a result of the interaction of cetirizine and pilsicainide in a patient with renal insufficiency: First case presentation showing competition for excretion via renal multidrug resistance protein 1 and organic cation transporter 2.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 389, doi. 10.1016/j.clpt.2005.12.302
- By:
- Publication type:
- Article
Correction.
- Published in:
- 2006
- Publication type:
- Correction Notice
Correction.
- Published in:
- 2006
- Publication type:
- Correction Notice
A message from the ASCPT Membership Committee Chairperson.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 397, doi. 10.1016/j.clpt.2006.01.002
- By:
- Publication type:
- Article
Welcome new ASCPT Members.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 4, p. 397, doi. 10.1016/j.clpt.2006.02.001
- Publication type:
- Article